These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

604 related articles for article (PubMed ID: 25173220)

  • 21. A higher correlation of HCV core antigen with CD4+ T cell counts compared with HCV RNA in HCV/HIV-1 coinfected patients.
    Shen T; Chen X; Zhang W; Xi Y; Cao G; Zhi Y; Wang S; Xu C; Wei L; Lu F; Zhuang H
    PLoS One; 2011; 6(8):e23550. PubMed ID: 21858166
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Biochemical and virologic parameters in patients co-infected with hepatitis C and HIV versus patients with hepatitis C mono-infection.
    Butt AA; Tsevat J; Ahmad J; Shakil AO; Mrus JM
    Am J Med Sci; 2007 May; 333(5):271-5. PubMed ID: 17505167
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Replication Inhibition of Hepatitis B Virus and Hepatitis C Virus in Co-Infected Patients in Chinese Population.
    Yu G; Chi X; Wu R; Wang X; Gao X; Kong F; Feng X; Gao Y; Huang X; Jin J; Qi Y; Tu Z; Sun B; Zhong J; Pan Y; Niu J
    PLoS One; 2015; 10(9):e0139015. PubMed ID: 26422607
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Comprehensive longitudinal analysis of hepatitis C virus (HCV)-specific T cell responses during acute HCV infection in the presence of existing HIV-1 infection.
    van den Berg CH; Ruys TA; Nanlohy NM; Geerlings SE; van der Meer JT; Mulder JW; Lange JA; van Baarle D
    J Viral Hepat; 2009 Apr; 16(4):239-48. PubMed ID: 19222746
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Effect of control selection on sustained viral response rates in genotype 2/3 HCV mono-infected versus HIV/HCV co-infected patients.
    Nilsson J; Weiland O
    Scand J Infect Dis; 2010 Jul; 42(6-7):533-9. PubMed ID: 20214543
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Prevalence of occult hepatitis B & C in HIV patients infected through sexual transmission.
    Rai RR; Mathur A; Mathur D; Udawat HP; Nepalia S; Nijhawan S; Mathur A
    Trop Gastroenterol; 2007; 28(1):19-23. PubMed ID: 17896605
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A comparison of the prevalence of autoantibodies in individuals with chronic hepatitis C and those with autoimmune hepatitis: the role of interferon in the development of autoimmune diseases.
    Bayraktar Y; Bayraktar M; Gurakar A; Hassanein TI; Van Thiel DH
    Hepatogastroenterology; 1997; 44(14):417-25. PubMed ID: 9164512
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Virologic and histologic characterisation of dual hepatitis B and C co-infection in Egyptian patients.
    Mekky MA; Nasr AM; Saleh MA; Wasif NK; Khalaf M; Aboalam H; Haredy M
    Arab J Gastroenterol; 2013 Dec; 14(4):143-7. PubMed ID: 24433642
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Hepatitis C virus coinfection and HIV load, CD4+ cell percentage, and clinical progression to AIDS or death among HIV-infected women: Women and Infants Transmission Study.
    Hershow RC; O'Driscoll PT; Handelsman E; Pitt J; Hillyer G; Serchuck L; Lu M; Chen KT; Yawetz S; Pacheco S; Davenny K; Adeniyi-Jones S; Thomas DL
    Clin Infect Dis; 2005 Mar; 40(6):859-67. PubMed ID: 15736020
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Low current and nadir CD4+ T-cell counts are associated with higher hepatitis C virus RNA levels in the Swiss HIV cohort study.
    Rauch A; Gaudieri S; Evison J; Nolan D; Cavassini M; Weber R; James I; Furrer H;
    Antivir Ther; 2008; 13(3):455-60. PubMed ID: 18572759
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Liver injury and changes in hepatitis C Virus (HCV) RNA load associated with protease inhibitor-based antiretroviral therapy for treatment-naive HCV-HIV-coinfected patients: lopinavir-ritonavir versus nelfinavir.
    Sherman KE; Shire NJ; Cernohous P; Rouster SD; Omachi JH; Brun S; Da Silva B
    Clin Infect Dis; 2005 Oct; 41(8):1186-95. PubMed ID: 16163639
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Epidemiological, immunological and virological characteristics, and disease progression of HIV-1/HCV-co-infected patients from a southern Brazilian population.
    Reiche EM; Bonametti AM; Morimoto HK; Morimoto AA; Wiechemann SL; Matsuo T; Vissoci Reiche F; Vogler IH
    Int J Mol Med; 2008 Mar; 21(3):387-95. PubMed ID: 18288387
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Spontaneous viral clearance, viral load, and genotype distribution of hepatitis C virus (HCV) in HIV-infected patients with anti-HCV antibodies in Europe.
    Soriano V; Mocroft A; Rockstroh J; Ledergerber B; Knysz B; Chaplinskas S; Peters L; Karlsson A; Katlama C; Toro C; Kupfer B; Vogel M; Lundgren J;
    J Infect Dis; 2008 Nov; 198(9):1337-44. PubMed ID: 18767985
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Quantitation of hepatitis C virus RNA in peripheral blood mononuclear cells in HCV-monoinfection and HIV/HCV-coinfection.
    Chary A; Winters MA; Eisen R; Knight TH; Asmuth DM; Holodniy M
    J Med Virol; 2012 Mar; 84(3):431-7. PubMed ID: 22246828
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Analysis of causes for liver function deterioration in patients with HIV/HCV co-infection.
    Zhang YH; Chen XY; Jiang Y; Xiao Y; Liu Z; Long XS; Wu H
    Hepatobiliary Pancreat Dis Int; 2004 Nov; 3(4):538-42. PubMed ID: 15567741
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Hepatitis C virus infection in patients with tuberculosis in Central Brazil.
    Reis NR; Lopes CL; Teles SA; Matos MA; Carneiro MA; Marinho TA; Filho JA; Espírito-Santo MP; Lampe E; Martins RM
    Int J Tuberc Lung Dis; 2011 Oct; 15(10):1397-402. PubMed ID: 22283901
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Higher dN/dS ratios in the HCV core gene, but not in the E1/HVR1 gene, are associated with human immunodeficiency virus-associated immunosuppression.
    Xu CH; Shen T; Zheng JJ; Tu J; Zhang WD; Lu FM
    Arch Virol; 2012 Nov; 157(11):2153-62. PubMed ID: 22825695
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Performance characteristics of a combined hepatitis C virus core antigen and anti-hepatitis C virus antibody test in different patient groups.
    Yang JF; Lin YY; Hsieh MH; Tsai CH; Liu SF; Yu ML; Dai CY; Huang JF; Lin WY; Lin ZY; Chen SC; Chuang WL
    Kaohsiung J Med Sci; 2011 Jul; 27(7):258-63. PubMed ID: 21757142
    [TBL] [Abstract][Full Text] [Related]  

  • 39. High rates of active hepatitis B and C co-infections in HIV-1 infected Cameroonian adults initiating antiretroviral therapy.
    Laurent C; Bourgeois A; Mpoudi-Ngolé E; Kouanfack C; Ciaffi L; Nkoué N; Mougnutou R; Calmy A; Koulla-Shiro S; Ducos J; Delaporte E
    HIV Med; 2010 Jan; 11(1):85-9. PubMed ID: 19659944
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Quantitative assessment of HCV load in chronic hemodialysis patients: a cross-sectional survey.
    Fabrizi F; Martin P; Dixit V; Brezina M; Cole MJ; Gerosa S; Vinson S; Mousa M; Gitnick G
    Nephron; 1998 Dec; 80(4):428-33. PubMed ID: 9832642
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 31.